| Serial Number | 90272627 |
| Word Mark | STILLWATER |
| Filing Date | Thursday, October 22, 2020 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Friday, July 12, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 24, 2022 |
| Goods and Services | Providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders |
| Goods and Services | Pharmaceutical research and development services; conducting clinical trials for others for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders, and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, December 12, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, December 12, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Party Name | Neurocrine Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Event Date | Event Description |
| Monday, October 26, 2020 | NEW APPLICATION ENTERED |
| Saturday, December 19, 2020 | NON-FINAL ACTION WRITTEN |
| Saturday, December 12, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, December 15, 2020 | ASSIGNED TO EXAMINER |
| Monday, June 21, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, December 19, 2020 | NON-FINAL ACTION E-MAILED |
| Saturday, December 19, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 21, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 22, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 26, 2021 | SUSPENSION LETTER WRITTEN |
| Monday, July 26, 2021 | LETTER OF SUSPENSION E-MAILED |
| Monday, July 26, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, February 22, 2022 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Thursday, April 14, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, April 18, 2022 | ASSIGNED TO LIE |
| Tuesday, May 24, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 4, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, January 6, 2023 | SOU EXTENSION 1 GRANTED |
| Tuesday, May 24, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 19, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, January 6, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, January 6, 2023 | SOU EXTENSION 1 FILED |
| Wednesday, July 5, 2023 | SOU EXTENSION 2 FILED |
| Tuesday, January 10, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, July 5, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, July 5, 2023 | SOU EXTENSION 2 GRANTED |
| Friday, July 7, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, July 12, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, July 12, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, July 12, 2024 | SOU EXTENSION 4 FILED |
| Friday, July 12, 2024 | SOU EXTENSION 4 GRANTED |
| Tuesday, January 16, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 16, 2024 | SOU EXTENSION 3 FILED |
| Tuesday, January 16, 2024 | SOU EXTENSION 3 GRANTED |
| Thursday, January 18, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |